Clinical trial
Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in…
NCT00196755 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00196755 |
|---|---|
| Title | Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis |
| Official title | An Open Label, Randomized, Parallel Design Study to Investigate the Efficacy and Safety of Sevelamer Hydrochloride (Renagel®) Compared With Calcium Acetate in Peritoneal Dialysis Patients |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Peritoneal Dialysis, Chronic Kidney Disease |
| Intervention type | Drug |
| Interventions | Sevelamer Hydrochloride (Renagel®), Calcium acetate (PhosLo® ) |
| Enrollment | 138 |
| Start date | Dec 1, 2004 |
| Primary completion | Mar 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 18, 2015 |
| Countries | Belgium, Denmark, France, Italy, Netherlands, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: